# Study to Evaluate a Single Dose of STI-2020 (COVI-AMG™) in Adults With Mild COVID-19 Symptoms

> **NCT04734860** · PHASE2 · WITHDRAWN · sponsor: **Sorrento Therapeutics, Inc.**

## Conditions studied

- Covid19

## Interventions

- **BIOLOGICAL:** COVI-AMG
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04734860
- **Lead sponsor:** Sorrento Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2021-04
- **Primary completion:** 2021-09
- **Final completion:** 2021-11
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** A different study will be conducted.
- **Last updated:** 2022-02-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04734860

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04734860, "Study to Evaluate a Single Dose of STI-2020 (COVI-AMG™) in Adults With Mild COVID-19 Symptoms". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04734860. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*